SOP for global ethics compliance – Clinical Research Made Simple

SOP for EC/IRB Communications (Minutes, Decisions, Correspondence)

digi — Sat, 09 Aug 2025 10:00:08 +0000

SOP for EC/IRB Communications (Minutes, Decisions, Correspondence)

{
“@context”: “https://schema.org”,
“@type”: “Article”,
“mainEntityOfPage”: {
“@type”: “WebPage”,
“@id”: “https://www.Clinicalstudies.in/SOP-for-EC-IRB-Communications-Minutes-Decisions-Correspondence”
},
“headline”: “SOP for Ethics Committee and IRB Communications (Minutes, Decisions, Correspondence)”,
“description”: “This SOP outlines procedures for recording and managing Ethics Committee (EC) and Institutional Review Board (IRB) communications, including minutes, decisions, and correspondence, in compliance with ICH GCP, WHO, FDA, EMA, and CDSCO guidelines.”,
“author”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”
},
“publisher”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”,
“logo”: {
“@type”: “ImageObject”,
“url”: “https://www.clinicalstudies.in/logo.png”
}
},
“datePublished”: “2025-08-26”,
“dateModified”: “2025-08-26”
}

Standard Operating Procedure for EC/IRB Communications (Minutes, Decisions, Correspondence)

Department	Clinical Research
SOP No.	CR/ETH/010/2025
Supersedes	NA
Page No.	1 of 22
Issue Date	26/08/2025
Effective Date	01/09/2025
Review Date	01/09/2026

Purpose

The purpose of this SOP is to establish standardized procedures for documenting and managing all communications with Ethics Committees (EC) and Institutional Review Boards (IRB), including meeting minutes, decisions, approval letters, and correspondence. This ensures transparency, accountability, and compliance with ICH GCP, WHO, FDA, EMA, and CDSCO requirements.

Scope

This SOP applies to all EC/IRB secretariat staff, investigators, sponsors, and regulatory personnel involved in preparing, distributing, and archiving EC/IRB communications for clinical trials. It covers routine communications, formal decisions, minutes of meetings, and correspondence with sponsors or investigators.

Responsibilities

EC/IRB Chairperson: Ensures minutes accurately reflect deliberations and decisions.
EC/IRB Secretariat: Prepares minutes, distributes decisions, and maintains correspondence logs.
Investigators: Respond promptly to EC/IRB queries and implement required actions.
Quality Assurance Officer: Reviews communication records for completeness and compliance.
Head of Clinical Research: Oversees adherence to SOP and approves major communications if required.

Accountability

The EC/IRB Secretariat is accountable for ensuring accurate, timely, and secure documentation of all communications. Incomplete or inaccurate records may lead to regulatory non-compliance or invalidation of EC/IRB decisions.

Procedure

1. Preparation of Meeting Minutes
Secretariat drafts meeting minutes within 7 working days of EC/IRB meeting.
Minutes must include quorum details, list of attendees, protocol numbers reviewed, summary of discussions, and decisions taken.
Chairperson reviews and signs final version before distribution.

2. Recording Decisions
All EC/IRB decisions (approval, conditional approval, deferral, or disapproval) must be documented.
Decision letters must be issued to investigators and sponsors within 10 working days.
Copies must be filed in the EC/IRB Communication Log and Trial Master File (TMF).

3. Handling Correspondence
Secretariat maintains a log of all incoming and outgoing communications (letters, emails, faxes).
Each correspondence must include date, sender/receiver, subject, and reference number.
Critical correspondence must be acknowledged in writing.

4. Distribution of Communications
Copies of decisions, approvals, and minutes must be shared with investigators, sponsors, and regulatory authorities (if applicable).
Distribution must be documented in Communication Tracker.

5. Documentation and Archiving
All communications must be archived securely with restricted access.
Records must be retained for a minimum of 5 years after trial completion or longer if required by local regulations.

Abbreviations

SOP: Standard Operating Procedure
EC: Ethics Committee
IRB: Institutional Review Board
TMF: Trial Master File
QA: Quality Assurance

Documents

EC/IRB Meeting Minutes Template (Annexure-1)
Decision Letter Template (Annexure-2)
Communication Log (Annexure-3)

References

ICH E6(R2) – Good Clinical Practice
US FDA 21 CFR Part 56 – IRB Regulations
EMA Clinical Trial Regulation (EU No. 536/2014)
WHO Guidelines for Ethics Committees
CDSCO Clinical Trial Rules, 2019

Version: 1.0

Approval Section

Prepared By	Rajesh Kumar, EC/IRB Secretariat Officer
Checked By	Sunita Reddy, QA Officer
Approved By	Dr. Anil Sharma, EC/IRB Chairperson

Annexures

Annexure-1: EC/IRB Meeting Minutes Template

Date	Protocol No.	Discussion Summary	Decision	Remarks
10/09/2025	CTP-2025-06	Protocol reviewed with quorum	Approved	Condition: submit updated ICF

Annexure-2: Decision Letter Template

Date	Protocol No.	Decision	Communicated To	Signed By
15/09/2025	CTP-2025-06	Approval Granted	Principal Investigator	EC Chairperson

Annexure-3: Communication Log

Date	Sender/Receiver	Subject	Reference No.	Remarks
12/09/2025	EC Secretariat to Sponsor	Decision letter – Protocol CTP-2025-06	EC-2025-045	Sent via email

Revision History

Revision Date	Revision No.	Revision Details	Reason for Revision	Approved By
26/08/2025	00	Initial version	New SOP creation	Head, Clinical Research

For more SOPs visit: Pharma SOP

SOP for EC Quorum and Conflict of Interest Handling

digi — Fri, 08 Aug 2025 19:23:20 +0000

SOP for EC Quorum and Conflict of Interest Handling

{
“@context”: “https://schema.org”,
“@type”: “Article”,
“mainEntityOfPage”: {
“@type”: “WebPage”,
“@id”: “https://www.Clinicalstudies.in/SOP-for-EC-Quorum-and-Conflict-of-Interest-Handling”
},
“headline”: “SOP for Ethics Committee Quorum and Conflict of Interest Handling”,
“description”: “This SOP describes regulatory-compliant procedures for managing Ethics Committee (EC)/IRB quorum requirements and handling conflicts of interest, in alignment with ICH GCP, WHO, FDA, EMA, and CDSCO standards.”,
“author”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”
},
“publisher”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”,
“logo”: {
“@type”: “ImageObject”,
“url”: “https://www.clinicalstudies.in/logo.png”
}
},
“datePublished”: “2025-08-26”,
“dateModified”: “2025-08-26”
}

Standard Operating Procedure for EC Quorum and Conflict of Interest Handling

Department	Clinical Research
SOP No.	CR/ETH/009/2025
Supersedes	NA
Page No.	1 of 20
Issue Date	26/08/2025
Effective Date	01/09/2025
Review Date	01/09/2026

Purpose

The purpose of this SOP is to define the procedures for ensuring that Ethics Committee (EC)/Institutional Review Board (IRB) meetings meet quorum requirements and for managing conflicts of interest (COI) among members. This guarantees unbiased decision-making, participant safety, and compliance with international and local regulatory requirements.

Scope

This SOP applies to all EC/IRB members, secretariat staff, investigators, and sponsors involved in clinical trials reviewed by the EC/IRB. It covers quorum establishment, conflict of interest disclosure, member recusal, documentation, and record-keeping.

Responsibilities

EC/IRB Chairperson: Ensures quorum is met before review or approval of any protocol and manages COI declarations.
EC/IRB Secretariat: Maintains attendance logs, COI declarations, and meeting minutes.
EC/IRB Members: Disclose any conflict of interest prior to participation in protocol review.
Quality Assurance Officer: Verifies compliance with quorum and COI handling requirements.
Head of Clinical Research: Oversees adherence to SOP at institutional level.

Accountability

The EC/IRB Chairperson is accountable for ensuring that all meetings adhere to quorum and COI handling requirements. Any deviation may render decisions invalid and result in regulatory non-compliance.

Procedure

1. Quorum Requirements
A quorum is defined as at least 5 voting members, including at least one lay person, one member with medical/scientific expertise, and one member independent of the institution (as per ICH GCP and national guidelines).
Meetings without quorum shall be rescheduled; decisions made without quorum are invalid.

2. Attendance Recording
EC/IRB Secretariat records attendance at each meeting.
Attendance log must include name, designation, role (voting/non-voting), and signature.

3. Conflict of Interest (COI) Disclosure
All members must declare COI before discussion of any protocol where they have financial, academic, or personal interest.
Declarations must be documented in the COI Register (Annexure-2).

4. COI Management
Members with COI shall leave the meeting room during discussion and decision-making.
Their absence and recusal must be recorded in meeting minutes.

5. Documentation and Record Keeping
Secretariat files attendance logs, COI declarations, and minutes in EC/IRB records.
Records are archived in compliance with ICH GCP and local requirements.